DEMO DAY

The Insides Company

Breakthrough devices enabling chyme reinfusion in patients with complex intestinal diseases
Q+A Video
yEAR FOUNDED
$18M
Pre-Money Valuation
$4M
Target Round Size
$2.5M
Total Capital Committed
Series A
Investment Stage
The Insides Company

Breakthrough devices enabling chyme reinfusion in patients with complex intestinal diseases

The Insides Company is the developer and manufacturer of therapeutic chyme rein fusion solutions for patients with intestinal failure, resulting from enterocutaneous fistulas or high output enterostomies. Founded by world-leading pioneers in gut nutrition and commercialised by med-tech veterans. The Insides System has been granted “Breakthrough Device Designation” by the USFDA and is now commercially available in the United Kingdom, Europe, and New Zealand.

RSVP for follow on Q+A

11:00am, Thursday 3 June

RSVP

Resources

The Insides Company Pitch Deck
The Insides Company Q+A

Demo Day Feedback Form

Ready to make a commitment?

Backing NZ’s bravest founders building global companies.

Make a Commitment